Bariatric surgery and calcifediol treatment, Gordian knot of severe-obesity-related comorbidities treatment

被引:2
|
作者
Herrera-Martinez, Aura D. [1 ,2 ]
Castillo-Peinado, Laura L. S. [1 ,3 ,4 ,5 ]
Molina-Puerta, Maria J. [1 ,2 ]
Calanas-Continente, Alfonso [1 ,2 ]
Membrives, Antonio [1 ,6 ]
Castilla, Juan [1 ,6 ]
Camacho Cardenosa, Marta [1 ]
Casado-Diaz, Antonio [1 ,5 ]
Galvez-Moreno, Maria A. [1 ,2 ]
Gahete, Manuel D. [1 ,7 ,8 ]
Quesada Gomez, Jose Manuel [1 ,2 ,7 ]
Bouillon, Roger [9 ]
Priego-Capote, Feliciano [1 ,3 ,4 ,5 ]
Luque, Raul M. [1 ,7 ,8 ]
机构
[1] Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain
[2] Reina Sofia Univ Hosp, Endocrinol & Nutr Serv, Cordoba, Spain
[3] Univ Cordoba, Dept Analyt Chem, Cordoba, Spain
[4] Univ Cordoba, Chem Inst Energy & Environm IQUEMA, Cordoba, Spain
[5] Inst Salud Carlos III, CIBER Fragilidad & Envejecimiento Saludable CIBERF, Madrid, Spain
[6] Reina Sofia Univ Hosp, Gen Surg Serv, Cordoba, Spain
[7] CIBER Fisiopatol Obes & Nutr CIBERobn, Cordoba, Spain
[8] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain
[9] Katholieke Univ Leuven, Dept Chron Dis & Metab, Clin & Expt Endocrinol, Leuven, Belgium
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
obesity; bariatric surgery; inflammasome; vitamin D; comorbidities; VITAMIN-D STATUS; SERUM 25-HYDROXYVITAMIN D; WEIGHT-LOSS; METABOLIC SYNDROME; ADIPOSE-TISSUE; NLRP3; MASS; MECHANISMS; SUPPLEMENTATION; ASSOCIATIONS;
D O I
10.3389/fendo.2023.1243906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Obesity (OB) is a chronic metabolic disease with important associated comorbidities and mortality. Vitamin D supplementation is frequently administered after bariatric surgery (BS), so as to reduce OB-related complications, maybe including chronic inflammation.Aim: This study aimed to explore relations between vitamin D metabolites and components of the inflammasome machinery in OB before and after BS and their relations with the improvement of metabolic comorbidities.Patients and methods: Epidemiological/clinical/anthropometric/biochemical evaluation was performed in patients with OB at baseline and 6 months after BS. Evaluation of i) vitamin-D metabolites in plasma and ii) components of the inflammasome machinery and inflammatory-associated factors [NOD-like-receptors (NLRs), inflammasome-activation-components, cytokines and inflammation/apoptosis-related components, and cell-cycle and DNA-damage regulators] in peripheral blood mononuclear cells (PBMCs) was performed at baseline and 6 months after BS. Clinical and molecular correlations/associations were analyzed.Results: Significant correlations between vitamin D metabolites and inflammasome-machinery components were observed at baseline, and these correlations were significantly reduced 6 months after BS in parallel to a decrease in inflammation markers, fat mass, and body weight. Treatment with calcifediol remarkably increased 25OHD levels, despite 24,25(OH)2D3 remained stable after BS. Several inflammasome-machinery components were associated with improvement in metabolic comorbidities, especially hypertension and dyslipidemia.Conclusion: The beneficial effects of vitamin D on OB-related comorbidities after BS patients are associated with significant changes in the molecular expression of key inflammasome-machinery components. The expression profile of these inflammasome components can be dynamically modulated in PBMCs after BS and vitamin D supplementation, suggesting that this profile could likely serve as a sensor and early predictor of the reversal of OB-related complications after BS.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?
    Kloock, Simon
    Ziegler, Christian G.
    Dischinger, Ulrich
    PHARMACOLOGY & THERAPEUTICS, 2023, 251
  • [2] Bariatric surgery for treatment of obesity
    Eldar, S.
    Heneghan, H. M.
    Brethauer, S. A.
    Schauer, P. R.
    INTERNATIONAL JOURNAL OF OBESITY, 2011, 35 : S16 - S21
  • [3] Bariatric surgery for treatment of obesity
    S Eldar
    H M Heneghan
    S A Brethauer
    P R Schauer
    International Journal of Obesity, 2011, 35 : S16 - S21
  • [4] Severe obesity and vitamin D deficiency treatment options before bariatric surgery: a randomized clinical trial
    Shahraki, Masoud Sayadi
    Khalili, Noushin
    Yousefvand, Shadi
    Sheikhbahaei, Erfan
    Shahmiri, Shahab Shahabi
    SURGERY FOR OBESITY AND RELATED DISEASES, 2019, 15 (09) : 1604 - 1611
  • [5] Surgical Approaches to the Treatment of Obesity: Bariatric Surgery
    Smith, Brian R.
    Schauer, Phil
    Nguyen, Ninh T.
    MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (05) : 1009 - +
  • [6] Managing severe obesity: understanding and improving treatment adherence in bariatric surgery
    Megan M. Hood
    Joyce Corsica
    Lauren Bradley
    Rebecca Wilson
    Diana A. Chirinos
    Amanda Vivo
    Journal of Behavioral Medicine, 2016, 39 : 1092 - 1103
  • [7] Managing severe obesity: understanding and improving treatment adherence in bariatric surgery
    Hood, Megan M.
    Corsica, Joyce
    Bradley, Lauren
    Wilson, Rebecca
    Chirinos, Diana A.
    Vivo, Amanda
    JOURNAL OF BEHAVIORAL MEDICINE, 2016, 39 (06) : 1092 - 1103
  • [8] Bariatric Surgery for Treatment of Obesity
    Weiner, R. A.
    Wechsler, J. G.
    AKTUELLE ERNAHRUNGSMEDIZIN, 2010, 35 (05): : 217 - 219
  • [9] Surgical Approaches to the Treatment of Obesity: Bariatric Surgery
    Smith, Brian R.
    Schauer, Phil
    Nguyen, Ninh T.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2008, 37 (04) : 943 - +
  • [10] Psychological Aspects of Bariatric Surgery as a Treatment for Obesity
    Jumbe, Sandra
    Hamlet, Claire
    Meyrick, Jane
    CURRENT OBESITY REPORTS, 2017, 6 (01): : 71 - 78